42 U.S.C. § 283q: Eureka prize competitions

Summary

The NIH Director must run prize competitions under existing prize authority to do one or both of two things. One goal is to find and fund biomedical research areas where prizes could lead to big advances. The other goal is to improve health outcomes for diseases or conditions that meet at least one of these tests: research investment is low compared to Federal spending on prevention and treatment (so prizes might cut Federal health costs), the condition is serious and causes a large burden in the United States, or the work could give a significant return on investment to the United States. The NIH Director must also collect information on how the prize-funded innovations affect scientific progress, health outcomes, and Federal spending. That information must be included in the NIH’s report issued every three years.

Title 42, §283q

The Public Health and Welfare, Source: USLM XML via OLRC

(a)In general

Pursuant to the authorities and processes established under section 3719 of title 15, the Director of the National Institutes of Health shall support prize competitions for one or both of the following goals:

(1)Identifying and funding areas of biomedical science that could realize significant advancements through a prize competition.

(2)Improving health outcomes, particularly with respect to human diseases and conditions—

(A)for which public and private investment in research is disproportionately small relative to Federal Government expenditures on prevention and treatment activities with respect to such diseases and conditions, such that Federal expenditures on health programs would be reduced;

(B)that are serious and represent a significant disease burden in the United States; or

(C)for which there is potential for significant return on investment to the United States.

(b)Tracking; reporting

The Director of the National Institutes of Health shall—

(1)collect information on—

(A)the effect of innovations funded through the prize competitions under this section in advancing biomedical science or improving health outcomes pursuant to subsection (a); and

(B)the effect of the innovations on Federal expenditures; and

(2)include the information collected under paragraph (1) in the triennial report under section 283 of this title (as amended by section 2032).

Editorial Notes

References in Text

section 2032, referred to in subsec. (b)(2), means section 2032 of Pub. L. 114–255. Codification Section was enacted as part of the 21st Century Cures Act, and not as part of the Public Health Service Act which comprises this chapter.

§283q Eureka Prize Competitions

Summary

Title 42, §283q

Notes & Related Subsidiaries

Editorial Notes

References in Text

Citations & Metadata